Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Aug 18;9(3):e003160. doi: 10.1136/rmdopen-2023-003160

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

PMC Copyright notice

Adjusted drug retention due to (A) remission and (B) total drug retention (excluding non-toxic reasons and remission). The adjusted confounders included baseline age; sex; disease duration; Clinical Disease Activity Index (CDAI); concomitant use of glucocorticoids; methotrexate and other conventional synthetic disease-modifying antirheumatic drugs (csDMARDs); number of switched biological DMARDs or JAKi; and prior use of TNFi, aIL-6R, CTLA4-Ig and JAKi. aIL-6R, anti-IL-6 receptor antibodies; CTLA4-Ig, cytotoxic T lymphocyte-associated antigen-4-Ig; JAKi, Janus kinase inhibitors; TNFi, tumour necrosis factor inhibitors.